Work

Kidney, Cardiovascular, and Death Outcomes with Semaglutide Treatment Among Two Race and Two Ethnic Groups: Post Hoc Analysis from the FLOW Trial

Year: 2025

Type: article

Source: Journal of the American Society of Nephrology

DOI: 10.1681/asn.2025nztajebj

Authors: Christian W. Mende, Carlos Campos, Richard E. Pratley, Katherine R. Tuttle, Sherif Mehanna, Caroline Swift, Soren Rasmussen, Peter Rossing, Vlado Perkovic, Kenneth W. Mahaffey

Institutions: University of California San Diego, AdventHealth Orlando, AdventHealth, Novo Nordisk (Denmark), Steno Diabetes Center Copenhagen, UNSW Sydney, Stanford Medicine, Stanford University

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDGs: Good health and well-being, Reduced inequalities

Open Access status: closed

OpenAlex ID: W4415474410

FWCI:

Cites:

Cited by:

Related to: 10